{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-177492","form_type":"8-K","ticker":"NPCE","cik":"0001528287","company_name":"NeuroPace Inc","filed_at":"2023-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.266629+00:00","generated_at":"2026-06-13T15:30:50.676459+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NeuroPace CEO Michael Favet resigns; Joel Becker appointed as new CEO effective July 10, 2023","bullets":["Michael Favet resigns as CEO and Board member effective July 10, 2023; will provide consulting services for 12 months at $600/hour.","Joel Becker appointed President and CEO effective July 10, 2023; also joins Board as Class I director through 2025 annual meeting.","Becker receives base salary of $520,000/year, target bonus of 75% of salary, and option grant of 380,424 shares vesting over 4 years.","Becker most recently served as President at Viking North Ventures; prior roles include Integer Holdings and St. Jude Medical.","Favet's unvested equity awards will be cancelled on August 1, 2023; vested options remain exercisable per award agreements."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-177492","json":"https://secwatch.observer/filing/0001193125-23-177492.json","markdown":"https://secwatch.observer/filing/0001193125-23-177492.md","text":"https://secwatch.observer/filing/0001193125-23-177492.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1528287/000119312523177492/0001193125-23-177492-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1528287/000119312523177492/d506395d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T15:30:50.676459+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2c239bcc1c","claim":"Michael Favet resigned as Director at NeuroPace Inc.","evidence_excerpt":"On June 27, 2023, Michael Favet resigned from his position as Chief Executive Officer of NeuroPace, Inc. and as a member of NeuroPace’s board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1528287/000119312523177492/0001193125-23-177492-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"4922324e67","claim":"Michael Favet resigned as Chief Executive Officer at NeuroPace Inc.","evidence_excerpt":"On June 27, 2023, Michael Favet resigned from his position as Chief Executive Officer of NeuroPace, Inc. and as a member of NeuroPace’s board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1528287/000119312523177492/0001193125-23-177492-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"d8e684f43d","claim":"Joel Becker was appointed as Director at NeuroPace Inc.","evidence_excerpt":"On June 28, 2023, NeuroPace appointed Joel Becker as Chief Executive Officer and as a member of the Board, in each case effective as of the Separation Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1528287/000119312523177492/0001193125-23-177492-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ddc9879213","claim":"Joel Becker was appointed as Chief Executive Officer at NeuroPace Inc.","evidence_excerpt":"On June 28, 2023, NeuroPace appointed Joel Becker as Chief Executive Officer and as a member of the Board, in each case effective as of the Separation Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1528287/000119312523177492/0001193125-23-177492-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}